From respiratory infection to fatal neurological disease, EHV-1 demands rapid PCR diagnosis, and detection protocols impact ...
Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...
The "Biosimilars Training Course (Mar 16th - Mar 17th, 2026)" training has been added to ResearchAndMarkets.com's offering. In today's pharmaceutical landscape, the rise of biosimilars presents a ...